Hytro manufactures garments with built-in blood flow restriction designed for use in training and recovery.
Hytro has raised $2.7M in total funding. The most recent round was Undisclosed. The last funding was announced in July 2025.
Hytro's investors include Lince Capital, Joyned Capital, Skin In The Game, Cameron Norrie, Sam Warburton.
Hytro is headquartered in London, United Kingdom.
Hytro manufactures garments with built-in blood flow restriction designed for use in training and recovery.
Hytro is at the Undisclosed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Hytro — Funding & Investors." VCBacked, July 30, 2025, https://www.vcbacked.co/company/hytro. Accessed August 14, 2026.
VCBacked. (2025). Hytro — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/hytro
{{cite web |title=Hytro — Funding & Investors |url=https://www.vcbacked.co/company/hytro |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated